EVOLUTE: Enfortumab Vedotin in OLder patients with locally advanced/metastatic UroThElial carcinoma

Ilgın Akbıyık, Mathilde Cabart, Arnaud Pagès, Leticia Aptecar, Mathilde Cancel, Helen Boyle, Théophile Bertail, Loïc Mourey, Cedric Pobel, Yohann Loriot, Natacha Naoun, Maxime Frélaut

Open source

DOI: 10.1016/j.clgc.2026.102660
Published: 2026-09
Container: Clinical Genitourinary Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clgc.2026.102660,
  title = {EVOLUTE: Enfortumab Vedotin in OLder patients with locally advanced/metastatic UroThElial carcinoma},
  author = {Ilgın Akbıyık and Mathilde Cabart and Arnaud Pagès and Leticia Aptecar and Mathilde Cancel and Helen Boyle and Théophile Bertail and Loïc Mourey and Cedric Pobel and Yohann Loriot and Natacha Naoun and Maxime Frélaut},
  year = {2026},
  journal = {Clinical Genitourinary Cancer},
  doi = {10.1016/j.clgc.2026.102660},
  url = {https://doi.org/10.1016/j.clgc.2026.102660}
}

RIS

TY  - JOUR
TI  - EVOLUTE: Enfortumab Vedotin in OLder patients with locally advanced/metastatic UroThElial carcinoma
AU  - Ilgın Akbıyık
AU  - Mathilde Cabart
AU  - Arnaud Pagès
AU  - Leticia Aptecar
AU  - Mathilde Cancel
AU  - Helen Boyle
AU  - Théophile Bertail
AU  - Loïc Mourey
AU  - Cedric Pobel
AU  - Yohann Loriot
AU  - Natacha Naoun
AU  - Maxime Frélaut
PY  - 2026
JO  - Clinical Genitourinary Cancer
DO  - 10.1016/j.clgc.2026.102660
UR  - https://doi.org/10.1016/j.clgc.2026.102660
ER  -

APA

Akbıyık, I., Cabart, M., Pagès, A., Aptecar, L., Cancel, M., Boyle, H., Bertail, T., Mourey, L., Pobel, C., Loriot, Y., Naoun, N., & Frélaut, M. (2026). EVOLUTE: Enfortumab Vedotin in OLder patients with locally advanced/metastatic UroThElial carcinoma. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2026.102660

Source records

crossref · retrieved 2026-09-25T14:17:25.753Z